DoD Bone Marrow Failure, Investigator-Initiated Research Award

Grant Name
DoD Bone Marrow Failure, Investigator-Initiated Research Award
Funder
Army Medical Research Acquisition Activity (AMRAA)
Department of Defense (DOD)
Country or Region
United States
Research Field
Science and Technology and other Research and Development
Deadline
Oct 09, 2024 12:00:00 AM EDT
Grant Size
2440000
Contact Info
Christopher L Baker Grants Officer Help@eBRAP.org
Eligibility

Eligible Applicants:

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Grant Number
HT942524BMFRPIIRA
Description

The FY24 BMFRP Investigator-Initiated Research Award (IIRA) will offer two funding levels with different intent:


Funding Level 1 (FL1): To support studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in research and/or patient care in the FY24 BMFRP Focus Areas. IIRA applications may involve translational and clinical research including studies in animal models, research with human data and/or anatomical substances, and research with human subjects, as well as correlative studies associated with a clinical trial(s); however, FL1 awards may not be used to support a clinical trial. An application that proposes a correlative study should be associated with a clinical trial(s), and the proposed study should address critical knowledge gaps in clinical outcomes, validate key research results, expand upon potentially game-changing results, or other impactful outcomes. Multidisciplinary collaborations are encouraged.


Funding Level 2 (FL2): To support Investigational New Drug (IND) application-enabling efforts. The BMFRP recognizes the scientific and financial challenges associated with advancing promising, potentially life-changing, therapeutic agents from the laboratory to clinical evaluation. Data related to lead compound characterization; formulation and stability; absorption, distribution, metabolism and excretion; dose/response; and toxicology are required before clinical trials can commence. The proposed studies under the FL2 IND-enabling efforts are expected to be empirical in nature, product-driven, and focused on the accumulation of data for a lead therapeutic candidate that will be included in an IND application submission to the U.S. Food and Drug Administration (FDA). At least one and no more than three lead therapeutic candidates must be named at the time of application submission to meet the intent of the FL2 mechanism. Library screening or drug optimization studies do not meet the intent of FL2. The intent of FL2 awards is to perform the necessary evaluation of promising therapies that will lead to clinical trials; however, clinical trials themselves are not supported by this mechanism. FL2 applications must address the FY24 BMFRP Focus Area, “Find effective BMF treatments and cures.”

Funding resources

Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

Oct 09, 2024 12:00:00 AM EDT

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

Related opportunities

Ovarian Cancer Research Program Investigator-Initiated Research Award
Science and Technology and other Researc... Aug 06, 2024 12:00:00 AM EDT 15360000
DoD, Melanoma, Focused Program Award - Rare Melanomas
Science and Technology and other Researc... Aug 26, 2024 12:00:00 AM EDT 6400000
Cyber-Physical Systems
Science and Technology and other Researc... Sep 03, 2024 12:00:00 AM EDT 7000000
Accessible and affordable tests to advance early detection of heritable cancers in European regions
Gender in health sciences 2024-09-18 €34999999
DoD Traumatic Brain Injury and Psychological Health, Focused Program Award
Science and Technology and other Researc... Oct 03, 2024 12:00:00 AM EDT 46500000
DoD Multiple Sclerosis, Early Investigator Research Award
Science and Technology and other Researc... Oct 07, 2024 12:00:00 AM EDT 1600000
NHMRC Partnership Projects 2024
Medical Research 27-Nov-2024 $31,600,000.00
Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT 295924
Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
Health Sep 30, 2025 12:00:00 AM EDT 300000
Aged Care Capital Assistance Program - Critical Infrastructure Projects
Aged Care 30-Jun-2027 $195,500,000.00